drugset / Trial / NCT03177889

Lung Dispersing, Turbid Descending and Gut Clearing Decoction for Bronchiectasis

NCT03177889

RandomizedCrossoverOpen-labelTreatment

Summary

Bronchiectasis is a chronic airway disease which confers significant healthcare burden, with limited therapeutic approaches. From the perspective of traditional Chinese medicine, congenital insufficiency of the lung, spleen and kidney, when coupled with external injury or mood impairment, may collectively contribute to bronchiectasis pathogenesis due to heat trapping in the phlems, congestion of wind evils and stagnation of blood. Here, the investigators will explore the Lung Dispersing, Turbid Descending and Gut Clearing Decoction (LTGD) which targets at expelling the wind evil in patients with bronchiectasis. The investigators sought to conduct a multicenter, randomized cross-over trial which investigates the efficacy and safety of LTGD on clinically stable bronchiectasis.

Timeline

Start
2021-12-31
Primary completion
2023-08-31
Completion
2023-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lung Dispersing, Turbid Descending and Gut Clearing Decoction Unknown
Background Ambroxol Small molecule 30 mg Oral
Background N-acetylcysteine Small molecule 0.2 g Oral
Background carbocisteine Unknown 500 mg Oral
Background serrapeptase Protein / enzyme biologic 10 mg Oral

Indications